Gilead Sciences officer sells 3,000 company shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Johanna Mercier, Chief Comm & Corp Aff Officer of Gilead Sciences, reported an open-market sale of 3,000 shares of common stock on 2026-07-15 at a reported price of $129.9192 per share, with trade prices ranging from $129.45 to $130.23. This sale was made under a Rule 10b5-1 trading plan adopted on February 20, 2025, and she now directly holds 121,234 Gilead shares.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F2 | 3,000 | $129.9192 | $390K |
Footnotes (2)
- F1. The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025.
- F2. Sale prices for the transactions reported range from $129.45 to $130.23. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
open-market sale financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider trade did Gilead Sciences (GILD) report for Johanna Mercier?
Was Johanna Mercier’s Gilead (GILD) stock sale under a Rule 10b5-1 plan?
What type of transaction did Johanna Mercier execute in Gilead (GILD) stock?
What does the price range in Johanna Mercier’s Gilead (GILD) sale represent?
AI-generated analysis. How Rhea-AI works. Not financial advice.